(Q47678683)
Statements
Mid-term results demonstrate salvage high-intensity focused ultrasound (HIFU) as an effective and acceptably morbid salvage treatment option for locally radiorecurrent prostate cancer (English)
Francois-Joseph Murat
Laura Poissonnier
Muriel Rabilloud
Raymonde Bouvier
Jean-Yves Chapelon